159 related articles for article (PubMed ID: 15959771)
21. Elevation of urinary globotriaosylceramide (GL3) in infants with Fabry disease.
Chien YH; Olivova P; Zhang XK; Chiang SC; Lee NC; Keutzer J; Hwu WL
Mol Genet Metab; 2011 Jan; 102(1):57-60. PubMed ID: 20864368
[TBL] [Abstract][Full Text] [Related]
22. An easy and sensitive method for determination of globotriaosylceramide (Gb3) from urinary sediment: utility for Fabry disease diagnosis and treatment monitoring.
Rozenfeld PA; De Francesco NP; Borrajo GJ; Ceci R; Fossati CA
Clin Chim Acta; 2009 May; 403(1-2):194-7. PubMed ID: 19268437
[TBL] [Abstract][Full Text] [Related]
23. Glycosphingolipid structural analysis and glycosphingolipidomics.
Levery SB
Methods Enzymol; 2005; 405():300-69. PubMed ID: 16413319
[TBL] [Abstract][Full Text] [Related]
24. Urinary total globotriaosylceramide and isoforms to identify women with Fabry disease: a diagnostic test study.
Paschke E; Fauler G; Winkler H; Schlagenhauf A; Plecko B; Erwa W; Breunig F; Urban W; Vujkovac B; Sunder-Plassmann G; Kotanko P
Am J Kidney Dis; 2011 May; 57(5):673-81. PubMed ID: 21186071
[TBL] [Abstract][Full Text] [Related]
25. Urinary globotriaosylceramide excretion correlates with the genotype in children and adults with Fabry disease.
Auray-Blais C; Cyr D; Ntwari A; West ML; Cox-Brinkman J; Bichet DG; Germain DP; Laframboise R; Melançon SB; Stockley T; Clarke JT; Drouin R
Mol Genet Metab; 2008 Mar; 93(3):331-40. PubMed ID: 18023222
[TBL] [Abstract][Full Text] [Related]
26. Screening for Fabry Disease by Urinary Globotriaosylceramide Isoforms Measurement in Patients with Left Ventricular Hypertrophy.
Gaggl M; Lajic N; Heinze G; Voigtländer T; Sunder-Plassmann R; Paschke E; Fauler G; Sunder-Plassmann G; Mundigler G
Int J Med Sci; 2016; 13(5):340-6. PubMed ID: 27226774
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical localization of glycosphingolipid in urinary renal tubular cells in Fabry's disease.
Chatterjee S; Gupta P; Pyeritz RE; Kwiterovich PO
Am J Clin Pathol; 1984 Jul; 82(1):24-8. PubMed ID: 6430064
[TBL] [Abstract][Full Text] [Related]
28. Structural characterization of neutral glycosphingolipids by thin-layer chromatography coupled to matrix-assisted laser desorption/ionization quadrupole ion trap time-of-flight MS/MS.
Nakamura K; Suzuki Y; Goto-Inoue N; Yoshida-Noro C; Suzuki A
Anal Chem; 2006 Aug; 78(16):5736-43. PubMed ID: 16906718
[TBL] [Abstract][Full Text] [Related]
29. Atmospheric pressure photoionization coupled to porous graphitic carbon liquid chromatography for the analysis of globotriaosylceramides. Application to Fabry disease.
Delobel A; Roy S; Touboul D; Gaudin K; Germain DP; Baillet A; Brion F; Prognon P; Chaminade P; Laprévote O
J Mass Spectrom; 2006 Jan; 41(1):50-8. PubMed ID: 16287034
[TBL] [Abstract][Full Text] [Related]
30. Risk of death in heart disease is associated with elevated urinary globotriaosylceramide.
Schiffmann R; Forni S; Swift C; Brignol N; Wu X; Lockhart DJ; Blankenship D; Wang X; Grayburn PA; Taylor MR; Lowes BD; Fuller M; Benjamin ER; Sweetman L
J Am Heart Assoc; 2014 Feb; 3(1):e000394. PubMed ID: 24496231
[TBL] [Abstract][Full Text] [Related]
31. The comparison of glycosphingolipids isolated from an epithelial ovarian cancer cell line and a nontumorigenic epithelial ovarian cell line using MALDI-MS and MALDI-MS/MS.
Rajanayake KK; Taylor WR; Isailovic D
Carbohydr Res; 2016 Aug; 431():6-14. PubMed ID: 27267063
[TBL] [Abstract][Full Text] [Related]
32. Interfering parameters in the determination of urinary globotriaosylceramide (Gb3) in patients with chronic kidney disease.
Gaggl M; Hofer M; Weidner S; Kleinert J; Fauler G; Wallner M; Kotanko P; Paschke E; Sunder-Plassmann G
J Nephrol; 2015 Dec; 28(6):679-89. PubMed ID: 25857295
[TBL] [Abstract][Full Text] [Related]
33. Enzyme replacement therapy for Fabry disease: morphologic and histochemical changes in the urinary sediments.
Utsumi K; Mitsuhashi F; Asahi K; Sakurazawa M; Arii K; Komaba Y; Katsumata T; Katsura K; Kase R; Katayama Y
Clin Chim Acta; 2005 Oct; 360(1-2):103-7. PubMed ID: 16112661
[TBL] [Abstract][Full Text] [Related]
34. Development of a filter paper method potentially applicable to mass and high-risk urinary screenings for Fabry disease.
Auray-Blais C; Cyr D; Mills K; Giguère R; Drouin R
J Inherit Metab Dis; 2007 Feb; 30(1):106. PubMed ID: 17171433
[TBL] [Abstract][Full Text] [Related]
35. Matching IR-MALDI-o-TOF mass spectrometry with the TLC overlay binding assay and its clinical application for tracing tumor-associated glycosphingolipids in hepatocellular and pancreatic cancer.
Distler U; Hülsewig M; Souady J; Dreisewerd K; Haier J; Senninger N; Friedrich AW; Karch H; Hillenkamp F; Berkenkamp S; Peter-Katalinić J; Müthing J
Anal Chem; 2008 Mar; 80(6):1835-46. PubMed ID: 18278947
[TBL] [Abstract][Full Text] [Related]
36. [Fabry's disease in children. Clinical and biological study of one family. Structure and ultrastructure of the kidney in a hemizygote and a heterozygote].
Desbois JC; Mazière JC; Gubler MC; Allaneau C; Verhaeghe MP; Herrault A
Ann Pediatr (Paris); 1977 Sep; 24(8-9):575-86. PubMed ID: 16211911
[No Abstract] [Full Text] [Related]
37. Convenient structural analysis of glycosphingolipids using MALDI-QIT-TOF mass spectrometry with increased laser power and cooling gas flow.
Suzuki Y; Suzuki M; Ito E; Goto-Inoue N; Miseki K; Iida J; Yamazaki Y; Yamada M; Suzuki A
J Biochem; 2006 Apr; 139(4):771-7. PubMed ID: 16672278
[TBL] [Abstract][Full Text] [Related]
38. Biochemical and clinical analysis of accumulated glycolipids in symptomatic heterozygotes of angiokeratoma corporis diffusum (Fabry's disease) in comparison with hemizygotes.
Hozumi I; Nishizawa M; Ariga T; Miyatake T
J Lipid Res; 1990 Feb; 31(2):335-40. PubMed ID: 2157788
[TBL] [Abstract][Full Text] [Related]
39. Rapid determination of urinary globotriaosylceramide isoform profiles by electrospray ionization mass spectrometry using stearoyl-d35-globotriaosylceramide as internal standard.
Fauler G; Rechberger GN; Devrnja D; Erwa W; Plecko B; Kotanko P; Breunig F; Paschke E
Rapid Commun Mass Spectrom; 2005; 19(11):1499-506. PubMed ID: 15880667
[TBL] [Abstract][Full Text] [Related]
40. The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease: a cross-sectional study of a large cohort of clinically affected heterozygous women.
Gupta S; Ries M; Kotsopoulos S; Schiffmann R
Medicine (Baltimore); 2005 Sep; 84(5):261-268. PubMed ID: 16148726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
